Innovation Pharmaceuticals Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Innovation Pharmaceuticals Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q2 2023.
  • Innovation Pharmaceuticals Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2023 was $39.4M, a 1.45% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $39.4M +$563K +1.45% Jun 30, 2023 10-K 2023-09-28
Q2 2022 $38.8M +$2.8M +7.79% Jun 30, 2022 10-K 2023-09-28
Q2 2021 $36M +$3.52M +10.8% Jun 30, 2021 10-K 2022-09-28
Q2 2020 $32.5M +$62.9M Jun 30, 2020 10-K 2021-09-27
Q2 2019 -$30.5M -$3.79M -14.2% Jun 30, 2019 10-K 2020-09-14
Q2 2018 -$26.7M -$55.6M -192% Jun 30, 2018 10-K 2019-09-30
Q2 2017 $28.9M +$7.05M +32.2% Jun 30, 2017 10-K 2018-09-11
Q2 2016 $21.9M +$5.38M +32.7% Jun 30, 2016 10-K 2017-09-11
Q2 2015 $16.5M +$5.71M +53% Jun 30, 2015 10-K 2016-09-13
Q2 2014 $10.8M +$3.62M +50.6% Jun 30, 2014 10-K 2015-09-11
Q2 2013 $7.15M +$1.36M +23.5% Jun 30, 2013 10-K 2014-09-15
Q2 2012 $5.79M +$1.28M +28.3% Jun 30, 2012 10-K 2013-09-30
Q2 2011 $4.52M Jun 30, 2011 10-K 2012-10-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.